Key result
Intravenous immunoglobulin treatment for acute viral myopericarditis in a 16-month-old girl was followed by the development of midventricular hypertrophy two weeks later.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
This case report highlights the rare development of mid-cavitary hypertrophy following acute viral myopericarditis treated with intravenous immunoglobulin in a pediatric patient.
A 16-month-old girl was referred for tachycardia and upper respiratory tract infection. Echocardiographic examination revealed pericardial effusion, mild mitral regurgitation, and left ventricle systolic dysfunction. Patient was positive for Parainfluenza type 4 virus. Her laboratory tests revealed increased troponin I level. The patient was treated with intravenous immunoglobulin considering acute viral myopericarditis. Two weeks after treatment, midventricular hypertrophy was detected.
No takes yet. Share an insight, caveat, or question.
Gürsu et al. (2022) conducted a case report in Acute viral myopericarditis (n=1). Intravenous immunoglobulin was evaluated on Midventricular hypertrophy. Intravenous immunoglobulin treatment for acute viral myopericarditis in a 16-month-old girl was followed by the development of midventricular hypertrophy two weeks later.
Synapse has enriched 10 related papers. Consider them for comparative context: